Lopinavir/ritonavir: increased risk of bleeding in haemophilia

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 982卷 / 1期
关键词：
Purpura; Ritonavir; Bleeding Complication; Indinavir; Saquinavir;
D O I：
10.2165/00128415-200309820-00010
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] Rosuvastatin concentrations increased with lopinavir/ritonavir
    Reactions Weekly, 2008, 1184 (1) : 5 - 5
  • [2] Increased bleeding in HIV-positive haemophiliac patients treated with lopinavir-ritonavir
    Yazdanpanah, Y
    Viget, N
    Cheret, A
    Guerroumi, H
    Gerard, Y
    Ajana, F
    Caron, J
    Mouton, Y
    AIDS, 2003, 17 (16) : 2397 - 2399
  • [3] Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir
    Tuija H. Nieminen
    Nora M. Hagelberg
    Teijo I. Saari
    Mikko Neuvonen
    Pertti J. Neuvonen
    Kari Laine
    Klaus T. Olkkola
    European Journal of Clinical Pharmacology, 2010, 66 : 977 - 985
  • [4] Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir
    Nieminen, Tuija H.
    Hagelberg, Nora M.
    Saari, Teijo I.
    Neuvonen, Mikko
    Neuvonen, Pertti J.
    Laine, Kari
    Olkkola, Klaus T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (10) : 977 - 985
  • [5] Increased risk of bleeding with the use of tipranavir boosted with ritonavir in haemophilic patients
    Arbuthnot, C.
    Wilde, J. T.
    HAEMOPHILIA, 2008, 14 (01) : 140 - 141
  • [6] Monotherapy with lopinavir/ritonavir
    Schechter, Mauro
    Nunes, Estevao Portela
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (05) : 735 - 741
  • [7] Lopinavir/Ritonavir in Pregnancy
    Roberts, Susan S.
    Martinez, Marisol
    Covington, Deborah L.
    Rode, Richard A.
    Pasley, Mary V.
    Woodward, William C.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (04) : 456 - 461
  • [8] Kaletra (lopinavir/ritonavir)
    Corbett, AH
    Lim, ML
    Kashuba, ADM
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (7-8) : 1193 - 1203
  • [9] The effect of lopinavir/ritonavir and lopinavir/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis
    Abou-El-Naga, Iman Fathy
    El Kerdany, Eman Dorry
    Mady, Rasha Fadly
    Shalaby, Thanaa Ibrahim
    Zaytoun, Enas Mohammed
    PARASITOLOGY INTERNATIONAL, 2017, 66 (06) : 735 - 747
  • [10] A comparative analysis of risk factors associated with efavirenz, darunavir/ritonavir, lopinavir/ritonavir, atazanavir/ritonavir and renal impairment
    Rockwood, N.
    Nelson, M.
    Mandalia, S.
    Sirokosta, J.
    Jones, R.
    Boffito, M.
    Gazzard, B.
    HIV MEDICINE, 2011, 12 : 1 - 1
12345